U.K. set to infect volunteers with coronavirus in world's first COVID-19 challenge study Hospitals could see 10% drop in admissions in 2020: KFF What will FDA's experts review at their first COVID-19 vaccine hearing? Agency documents set the tone Inhaled antibody drug for COVID-19 clears coronavirus in animals Biopharma roundup: AstraZeneca's US trial could restart this week Cigna, MDLive team up to offer virtual wellness exams Black Americans more skeptical than ever about COVID-19 vaccine: Harris Poll CMS: Average ACA plan premiums to drop by 2% in 2021 as more insurers join exchanges COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO Featured Story | By Nick Paul Taylor Researchers in the U.K. are set to deliberately infect young, healthy volunteers with SARS-CoV-2. The challenge study, which has £33.6 million ($43.6 million) in government support, could shed light on how people react to the virus and accelerate development of vaccines. read more |
| |
|---|
|
| | Webinar: The Power of Virtual Health Assessments during COVID Tuesday, October 27 | 11am ET / 8am PT COVID-19 has forced us to rethink how we effectively support members, and manage quality improvement and risk adjustment initiatives. This webinar provides a look at how Virtual Health Assessments improve healthcare outcomes for members, providers, and payers. Explore how Advantmed’s telehealth solution supports quality improvement and risk adjustment. Register Today. |
Top Stories By Tina Reed Overall, total hospital admissions dropped as low as 69% of predicted levels during the second week of April as stay-at-home orders required elective surgeries to be canceled, according to electronic medical record data from the Epic Health Research Network. read more By Eric Sagonowsky The countdown to the FDA's first coronavirus vaccine hearing has begun. More than seven months into the COVID-19 pandemic, with several vaccines in late-stage testing and developers preparing to file for widespread use, the FDA unveiled its plan for a Thursday advisory panel confab. read more By Angus Liu An inhaled neutralizing antibody cleared the novel coronavirus from infected hamsters at a far lower dose compared with other experimental monoclonal antibodies. The drug is now being developed by Aridis Pharmaceuticals and could offer a self-administered option for COVID-19 if it succeeds in human testing. read more By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner AstraZeneca's U.S. trial could resume this week, Reuters reports. Sinovac's shot proved safe after two doses, early phase 3 data showed. The FDA will set a "level playing field" for vaccine reviews at Thursday's AdComm confab. And Black Americans have grown more skeptical of a shot, The Harris Poll found. read more By Paige Minemyer Cigna and MDLive have joined forces to offer virtual wellness exams with the hope that these visits will serve as an on-ramp for patients who rarely interact with the healthcare system. read more By Beth Snyder Bulik Black Americans’ confidence in COVID-19 vaccines is plummeting. Only 43% of Black Americans now say they will get a vaccine once it's available, down 22 percentage points since August, The Harris Poll found. read more By Robert King The premiums for benchmark plans sold on the ACA's exchanges via HealthCare.gov are expected to decline by 2% in 2021 and more insurers are expected to sell plans, a new report finds. read more By Ben Adams The biotech behind AstraZeneca and the University of Oxford’s late-stage pandemic vaccine has hired Margaret (Meg) Marshall, M.D., as its new chief medical officer. read more |
